Shares of Incyte Corp. /zigman2/quotes/204510994/composite INCY -0.66% dropped 0.35% to $84.81 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.82% rising 0.02% to 4,227.26 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.80% falling 0.09% to 34,599.82. The stock's fall snapped a three-day winning streak. Incyte Corp. closed $25.56 below its 52-week high ($110.37), which the company achieved on July 7th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Pfizer Inc. /zigman2/quotes/202877789/composite PFE +3.91% fell 0.36% to $38.85, Novartis AG ADR /zigman2/quotes/203243705/composite NVS +0.48% rose 0.02% to $89.69, and Eli Lilly & Co. /zigman2/quotes/200106384/composite LLY +3.81% fell 0.82% to $220.70. Trading volume (960,619) remained 133,466 below its 50-day average volume of 1.1 M.